Evidence map›Paper›PMID 32511358›Full record

ArticlebioRxiv : the preprint server for biology2020

Rapid Isothermal Amplification and Portable Detection System for SARS-CoV-2.

A Ganguli, A Mostafa, J Berger, M Aydin, F Sun, E Valera, B T Cunningham, W P King, R Bashir

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 55 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

A GanguliDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Illinois, USA.
A MostafaDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Illinois, USA.
J BergerDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Illinois, USA.
M AydinDepartment of Mechanical Science and Engineering, University of Illinois at Urbana-Champaign, Illinois, USA.
F SunNick Holonyak Jr. Micro and Nanotechnology Laboratory, University of Illinois at Urbana-Champaign, Illinois, USA.
E ValeraDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Illinois, USA.
B T CunninghamDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Illinois, USA.
W P KingNick Holonyak Jr. Micro and Nanotechnology Laboratory, University of Illinois at Urbana-Champaign, Illinois, USA.
R BashirDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Illinois, USA.
University of Illinois Urbana-Champaign · US

Funding

Multiplexed Pathogen Detection from Whole Blood for Rapid Detection of SepsisR21AI146865 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BASHIR, RASHID · 2019 to 2020
$424k
NIAID NIH HHS R21 AI146865
6 · The paper itself

Abstract

The COVID-19 pandemic provides an urgent example where a gap exists between availability of state-of-the-art diagnostics and current needs. As assay details and primer sequences become widely known, many laboratories could perform diagnostic tests using methods such as RT-PCR or isothermal RT-LAMP amplification. A key advantage of RT-LAMP based approaches compared to RT-PCR is that RT-LAMP is known to be robust in detecting targets from unprocessed samples. In addition, RT-LAMP assays are performed at a constant temperature enabling speed, simplicity, and point-of-use testing. Here, we provide the details of an RT-LAMP isothermal assay for the detection of SARS-CoV-2 virus with performance comparable to currently approved tests using RT-PCR. We characterize the assay by introducing swabs in virus spiked synthetic nasal fluids, moving the swab to viral transport medium (VTM), and using a volume of that VTM for performing the amplification without an RNA extraction kit. The assay has a Limit-of-Detection (LOD) of 50 RNA copies/μL in the VTM solution within 20 minutes, and LOD of 5000 RNA copies/μL in the nasal solution. Additionally, we show the utility of this assay for real-time point-of-use testing by demonstrating detection of SARS-CoV-2 virus in less than 40 minutes using an additively manufactured cartridge and a smartphone-based reader. Finally, we explore the speed and cost advantages by comparing the required resources and workflows with RT-PCR. This work could accelerate the development and availability of SARS-CoV-2 diagnostics by proving alternatives to conventional laboratory benchtop tests.

Indexed as

Additive manufacturingCOVID19Isothermal amplificationLAMPPoint-of-careSARS-CoV-2Viral detection

Identifiers

PMID32511358
PMCPMC7263486
OpenAlexW3026514964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.